Iodine-124: A Promising Positron Emitter for Organic PET Chemistry
Reads0
Chats0
TLDR
The present review gives a survey on the use of 124I as promising PET radionuclide for molecular imaging and an outlook on the future prospective of using the long-lived positron emitter 124I in the field of organic PET chemistry and molecular imaging.Abstract:
The use of radiopharmaceuticals for molecular imaging of biochemical and physiological processes in vivo has evolved into an important diagnostic tool in modern nuclear medicine and medical research. Positron emission tomography (PET) is currently the most sophisticated molecular imaging methodology, mainly due to the unrivalled high sensitivity which allows for the studying of biochemistry in vivo on the molecular level. The most frequently used radionuclides for PET have relatively short half-lives (e.g. 11C: 20.4 min; 18F: 109.8 min) which may limit both the synthesis procedures and the time frame of PET studies. Iodine-124 (124I, t1/2 = 4.2 d) is an alternative long-lived PET radionuclide attracting increasing interest for long term clinical and small animal PET studies. The present review gives a survey on the use of 124I as promising PET radionuclide for molecular imaging. The first part describes the production of 124I. The second part covers basic radiochemistry with 124I focused on the synthesis of 124I-labeled compounds for molecular imaging purposes. The review concludes with a summary and an outlook on the future prospective of using the long-lived positron emitter 124I in the field of organic PET chemistry and molecular imaging.read more
Citations
More filters
Journal ArticleDOI
Matching chelators to radiometals for radiopharmaceuticals.
TL;DR: This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals.
Journal ArticleDOI
Radiopharmaceutical chemistry for positron emission tomography.
Zibo Li,Peter S. Conti +1 more
TL;DR: An overview of the most common chemical approaches for the synthesis of PET-labeled molecules is provided and the most recent developments and trends are highlighted.
Journal ArticleDOI
PET tracers based on Zirconium-89.
Yin Zhang,Hao Hong,Weibo Cai +2 more
TL;DR: With well-developed radiochemistry, commercial availability of chelating agents for (89)Zr labeling, increasingly widely available isotope supply, as well as successful proof-of-principle in pilot human studies, it is expected that PET imaging with (89]Zr-based tracers will be a constantly evolving and highly vibrant field in the near future.
Journal ArticleDOI
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
TL;DR: The topics covered in this review include labeling methods, biological targets, and the most recent preclinical or clinical data of some of the next generation of PET radiopharmaceuticals.
Journal ArticleDOI
Radiolabeling of Nanoparticles and Polymers for PET Imaging
TL;DR: Various approaches and methods for the labeling of potential drug delivery systems using positron emitters are described and discussed to provide the radiolabeled analog.
References
More filters
Journal ArticleDOI
Imaging in the era of molecular oncology
TL;DR: Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide 'on the spot' treatment.
Journal ArticleDOI
Positron emission tomography provides molecular imaging of biological processes.
TL;DR: A micro PET scanner for mice, in concert with human PET systems, provides a novel technology for molecular imaging assays of metabolism and signal transduction to gene expression, from mice to patients as discussed by the authors.
Journal Article
PET: The Merging of Biology and Imaging into Molecular Imaging
TL;DR: PET and SPECT are molecular imaging techniques that use radiolabeled molecules to image molecular interactions of biological processes in vivo as discussed by the authors, which can be used to titrate drugs to their sites of action within organ systems in vivo and to assay biological outcomes of the processes being modified in the mouse and the patient.
Journal ArticleDOI
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.
Peter L. Toogood,Patricia J. Harvey,Joseph T. Repine,Derek James Sheehan,Scott Norman Vanderwel,Hairong Zhou,Paul R. Keller,Mcnamara Dennis Joseph,Debra Ann Sherry,Tong Zhu,Joanne Brodfuehrer,Chung Choi,Mark R. Barvian,David W. Fry +13 more
TL;DR: It is demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.
Journal Article
Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Juri Gelovani Tjuvajev,Norbert Avril,Takamitsu Oku,Toshio Sasajima,Tadashi Miyagawa,Revathi Joshi,Michelle Safer,Bradley J. Beattie,Gene R. DiResta,Farhad Daghighian,Finn Augensen,Jason A. Koutcher,J Zweit,John L. Humm,Steven M. Larson,Ronald D. Finn,Ronald G. Blasberg +16 more
TL;DR: The ability to image the location (distribution) of gene expression and the level of expression over time provides new and useful information for monitoring clinical gene therapy protocols in the future.